JP2012530060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012530060A5 JP2012530060A5 JP2012515161A JP2012515161A JP2012530060A5 JP 2012530060 A5 JP2012530060 A5 JP 2012530060A5 JP 2012515161 A JP2012515161 A JP 2012515161A JP 2012515161 A JP2012515161 A JP 2012515161A JP 2012530060 A5 JP2012530060 A5 JP 2012530060A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmacological agent
- peptide
- seq
- agent according
- mast cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18594309P | 2009-06-10 | 2009-06-10 | |
| US61/185,943 | 2009-06-10 | ||
| PCT/US2010/038226 WO2010144742A2 (en) | 2009-06-10 | 2010-06-10 | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015134712A Division JP6238934B2 (ja) | 2009-06-10 | 2015-07-03 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012530060A JP2012530060A (ja) | 2012-11-29 |
| JP2012530060A5 true JP2012530060A5 (enExample) | 2013-07-04 |
| JP5886192B2 JP5886192B2 (ja) | 2016-03-16 |
Family
ID=43309471
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012515161A Expired - Fee Related JP5886192B2 (ja) | 2009-06-10 | 2010-06-10 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2015134712A Expired - Fee Related JP6238934B2 (ja) | 2009-06-10 | 2015-07-03 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2017179192A Expired - Fee Related JP6775478B2 (ja) | 2009-06-10 | 2017-09-19 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2020074428A Active JP7209364B2 (ja) | 2009-06-10 | 2020-04-17 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2022170797A Pending JP2023017813A (ja) | 2009-06-10 | 2022-10-25 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015134712A Expired - Fee Related JP6238934B2 (ja) | 2009-06-10 | 2015-07-03 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2017179192A Expired - Fee Related JP6775478B2 (ja) | 2009-06-10 | 2017-09-19 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2020074428A Active JP7209364B2 (ja) | 2009-06-10 | 2020-04-17 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
| JP2022170797A Pending JP2023017813A (ja) | 2009-06-10 | 2022-10-25 | 内在化ペプチド連結薬剤と抗炎症剤との共投与 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US8933013B2 (enExample) |
| EP (2) | EP3682895A1 (enExample) |
| JP (5) | JP5886192B2 (enExample) |
| AU (1) | AU2010259986B2 (enExample) |
| CA (2) | CA2765171C (enExample) |
| CY (1) | CY1122584T1 (enExample) |
| DK (1) | DK2440231T3 (enExample) |
| ES (1) | ES2765281T3 (enExample) |
| HR (1) | HRP20192230T1 (enExample) |
| HU (1) | HUE046640T2 (enExample) |
| LT (1) | LT2440231T (enExample) |
| PL (1) | PL2440231T3 (enExample) |
| PT (1) | PT2440231T (enExample) |
| SI (1) | SI2440231T1 (enExample) |
| SM (1) | SMT202000056T1 (enExample) |
| WO (1) | WO2010144742A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080518B2 (en) | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| PL2320927T3 (pl) * | 2008-07-09 | 2016-02-29 | Univ Copenhagen | Modyfikowane peptydy jako potencjalne inhibitory w reakcjach receptorów PSD 95 i NMD |
| PT2440231T (pt) * | 2009-06-10 | 2020-01-08 | Nono Inc | Co-administração de um agente ligado a um peptido de internalização tat com um inibidor de desgranulação de mastócitos |
| SI3354657T1 (sl) | 2009-09-22 | 2022-05-31 | Medicago Inc. | Postopek za pripravo iz rastlin izpeljanih beljakovin |
| TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
| HRP20220519T1 (hr) | 2011-06-24 | 2022-05-27 | Nono Inc. | Kombinacijska terapija ishemije |
| US10251935B2 (en) | 2012-11-28 | 2019-04-09 | Nono Inc. | Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose |
| TR201905787T4 (tr) * | 2012-11-28 | 2019-05-21 | Nono Inc | Liyofilize TAT-NR2B9C formülasyonu. |
| WO2016172219A1 (en) * | 2015-04-24 | 2016-10-27 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for inhibition of toll-like receptors (tlrs)-mediated inflammation |
| WO2017115853A1 (ja) | 2015-12-28 | 2017-07-06 | 出光興産株式会社 | ペプチドタグおよびそれを含むタグ付加タンパク質 |
| KR102403089B1 (ko) * | 2017-07-05 | 2022-06-02 | 바이오셀즈(베이징) 바이오테크 코., 엘티디. | 폴리펩타이드의 약학적으로 허용 가능한 염 및 이의 용도 |
| CN111417394B (zh) | 2017-10-19 | 2023-11-07 | 帝人制药株式会社 | 苯并咪唑衍生物及其用途 |
| AU2021206472A1 (en) * | 2020-01-09 | 2022-08-18 | Nono Inc. | Plasmin-resistant peptides for treating stroke and related conditions |
| EP4274596A4 (en) | 2021-01-08 | 2024-12-25 | NoNO Inc. | Plasmin-resistant peptides for improved therapeutic index |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5804604A (en) | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
| US6316003B1 (en) | 1989-12-21 | 2001-11-13 | Whitehead Institute For Biomedical Research | Tat-derived transport polypeptides |
| US5331573A (en) | 1990-12-14 | 1994-07-19 | Balaji Vitukudi N | Method of design of compounds that mimic conformational features of selected peptides |
| CA2354644A1 (en) | 1998-12-11 | 2000-06-15 | Biomira, Inc. | Muc-1 antagonists and methods of treating immune disorders |
| US20040226056A1 (en) | 1998-12-22 | 2004-11-11 | Myriad Genetics, Incorporated | Compositions and methods for treating neurological disorders and diseases |
| US20060148711A1 (en) | 1999-05-14 | 2006-07-06 | Arbor Vita Corporation | Molecular interactions in neurons |
| US7595297B2 (en) * | 1999-06-02 | 2009-09-29 | Michael Tymianski | Method of reducing injury to mammalian cells |
| US7510824B2 (en) * | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| DE60026313D1 (de) | 1999-07-23 | 2006-04-27 | Uutech Ltd | Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes |
| WO2001013957A2 (en) | 1999-08-24 | 2001-03-01 | Cellgate, Inc. | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| US6204245B1 (en) | 1999-09-17 | 2001-03-20 | The Regents Of The University Of California | Treatment of narcolepsy with immunosuppressants |
| US6864355B1 (en) | 2000-05-02 | 2005-03-08 | Yale University | Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| US20020032154A1 (en) | 2000-06-07 | 2002-03-14 | Peyman John A. | Interferon-suppressing placental lactogen peptides |
| WO2003024389A2 (en) | 2001-07-30 | 2003-03-27 | Immunex Corporation | T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using |
| CA2505479A1 (en) * | 2002-11-14 | 2004-06-03 | Arbor Vita Corporation | Molecular interactions in neurons |
| WO2004071531A1 (en) | 2003-02-13 | 2004-08-26 | Licentia Oy | Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia |
| US20050209141A1 (en) * | 2003-10-17 | 2005-09-22 | Silver Randi B | Mast cell-derived renin |
| US20050256065A1 (en) * | 2004-01-26 | 2005-11-17 | Permasight | Method for stabilizing changes in corneal curvature in an eye by administering compositions containing stabilizing ophthalmic agents |
| US7151084B2 (en) | 2004-12-27 | 2006-12-19 | Miller Landon C G | Compound and method of treating neurogenic conditions using non-steroidal anti-inflammatory drug complexes |
| KR101384572B1 (ko) | 2005-12-30 | 2014-04-24 | 아버 비타 코포레이션 | Ｐｄｚ 상호작용의 소형 분자 억제제 |
| CA2657665C (en) * | 2006-07-11 | 2015-06-02 | Arbor Vita Corporation | Method and compositions for treating stroke with fever |
| EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| ES2446292T3 (es) | 2007-03-02 | 2014-03-07 | Nono Inc. | Tratamiento del accidente cerebrovascular y otras enfermedades sin inhibir los canales de calcio de tipo N |
| WO2009006611A1 (en) | 2007-07-03 | 2009-01-08 | Arbor Vita Corporation | Small molecule inhibitors of pdz interactions |
| DK2178549T3 (en) | 2007-07-26 | 2017-01-09 | Revance Therapeutics Inc | Antimicrobial peptide AND COMPOSITIONS THEREOF |
| ES2328776B1 (es) | 2007-11-19 | 2010-07-06 | Proyecto De Biomedicina Cima S.L. | Peptidos con capacidad para unirse a escurfina y aplicaciones. |
| US8080518B2 (en) * | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| PL2320927T3 (pl) | 2008-07-09 | 2016-02-29 | Univ Copenhagen | Modyfikowane peptydy jako potencjalne inhibitory w reakcjach receptorów PSD 95 i NMD |
| PT2440231T (pt) | 2009-06-10 | 2020-01-08 | Nono Inc | Co-administração de um agente ligado a um peptido de internalização tat com um inibidor de desgranulação de mastócitos |
-
2010
- 2010-06-10 PT PT107868705T patent/PT2440231T/pt unknown
- 2010-06-10 HR HRP20192230TT patent/HRP20192230T1/hr unknown
- 2010-06-10 AU AU2010259986A patent/AU2010259986B2/en not_active Ceased
- 2010-06-10 ES ES10786870T patent/ES2765281T3/es active Active
- 2010-06-10 CA CA2765171A patent/CA2765171C/en active Active
- 2010-06-10 JP JP2012515161A patent/JP5886192B2/ja not_active Expired - Fee Related
- 2010-06-10 DK DK10786870.5T patent/DK2440231T3/da active
- 2010-06-10 SM SM20200056T patent/SMT202000056T1/it unknown
- 2010-06-10 PL PL10786870T patent/PL2440231T3/pl unknown
- 2010-06-10 EP EP19210675.5A patent/EP3682895A1/en not_active Withdrawn
- 2010-06-10 HU HUE10786870A patent/HUE046640T2/hu unknown
- 2010-06-10 WO PCT/US2010/038226 patent/WO2010144742A2/en not_active Ceased
- 2010-06-10 US US13/377,519 patent/US8933013B2/en active Active
- 2010-06-10 SI SI201031965T patent/SI2440231T1/sl unknown
- 2010-06-10 CA CA3018494A patent/CA3018494C/en active Active
- 2010-06-10 EP EP10786870.5A patent/EP2440231B1/en active Active
- 2010-06-10 LT LTEP10786870.5T patent/LT2440231T/lt unknown
-
2014
- 2014-12-29 US US14/585,028 patent/US9433685B2/en not_active Expired - Fee Related
-
2015
- 2015-07-03 JP JP2015134712A patent/JP6238934B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-24 US US15/245,693 patent/US10046060B2/en active Active
-
2017
- 2017-09-19 JP JP2017179192A patent/JP6775478B2/ja not_active Expired - Fee Related
-
2018
- 2018-07-12 US US16/034,235 patent/US20190038760A1/en not_active Abandoned
-
2019
- 2019-12-23 CY CY20191101350T patent/CY1122584T1/el unknown
-
2020
- 2020-04-17 JP JP2020074428A patent/JP7209364B2/ja active Active
-
2022
- 2022-10-25 JP JP2022170797A patent/JP2023017813A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8569235B2 (en) | Treatment of kidney disorders with VIP fragments | |
| US8933013B2 (en) | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory | |
| JP2011506328A5 (enExample) | ||
| JP2013521231A5 (enExample) | ||
| RU2014126484A (ru) | Нацеленные соединения лизосомальных ферментов | |
| IL224609A (en) | Intact and peptide intestinal fragments and methods of use | |
| JP2008501723A (ja) | 循環器病の治療のための組成物および方法 | |
| JP2014515747A5 (enExample) | ||
| CN105451756A (zh) | 在治疗马凡氏综合征及其相关病症中的血管紧张素肽 | |
| JP5283106B2 (ja) | Ｃ型肝炎ウイルス阻害剤 | |
| JP2016500001A5 (enExample) | ||
| JP5477794B2 (ja) | エンドキニンｃ／ｄ由来のペプチド | |
| JP2015533821A5 (enExample) | ||
| ES2639838T3 (es) | Péptidos inhibidores de la interacción entre ASF1 y las histonas, y sus usos | |
| JP2008156312A (ja) | サブスタンスｐに対するペプチド由来のアンタゴニストの開発 | |
| JP2009500314A5 (enExample) | ||
| 陳宥蓁 et al. | A Case Report of Endogenous Endophthalmitis Caused by Non-O1/Non-O139 Vibrio Cholerae | |
| HK1160598B (en) | Compositions and methods for treatment of kidney disorders |